Key result
Pharmacological VTE prophylaxis was significantly underused, with only 30.3% of high-risk inpatients receiving appropriate prophylaxis.
Why the study?
Venous thromboembolism is a prevalent and morbid inpatient complication, motivating the evaluation of prophylaxis practices and determinants of inappropriate use in general internal medicine wards to guide quality improvement.
Population
295 inpatients in general internal medicine wards of a tertiary-care university hospital
Comparison
Pharmacological VTE prophylaxis utilization assessed by Padua Prediction Score
Design
Cross-sectional study
Authors
Loading...
Highlights implementation gaps in VTE prevention; leaves open effective quality improvement strategies.
Cross-Sectional (n=295)
No
There is a significant underuse of VTE prophylaxis in high-risk general internal medicine inpatients, highlighting a major quality gap in clinical practice.
Güven et al. (2021) conducted a cross-sectional in Venous thromboembolism risk (n=295). Pharmacological venous thromboembolism prophylaxis was evaluated on Appropriate pharmacological prophylaxis in high-risk patients. Pharmacological VTE prophylaxis was significantly underused, with only 30.3% of high-risk inpatients receiving appropriate prophylaxis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: